• Development and validation of technology Final Dossage Form – sterile liquid and lyophilized vials, tablets and capsules for human and veterinary use
• Development and validation of analytical methods according to Ph.Eur., USP and Russian Pharmacopoeia requirements
• Development of Final Dosage Form Registration documentation for EU countries (CTD format)

Stability studies for Final Dosage Form according to ICH guidelines